Antiandrogens Act as Selective Androgen Receptor Modulators at the Proteome Level in Prostate Cancer Cells

Current therapies for prostate cancer include antiandrogens, inhibitory ligands of the androgen receptor, which repress androgen-stimulated growth. These include the selective androgen receptor modulators cyproterone acetate and hydroxyflutamide and the complete antagonist bicalutamide. Their activi...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooke, Greg N., Gamble, Simon C., Hough, Michael A., Begum, Shajna, Dart, D. Alwyn, Odontiadis, Michael, Powell, Sue M., Fioretti, Flavia M., Bryan, Rosie A., Waxman, Jonathan, Wait, Robin, Bevan, Charlotte L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424393/
https://www.ncbi.nlm.nih.gov/pubmed/25693800
http://dx.doi.org/10.1074/mcp.M113.036764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424393/
https://www.ncbi.nlm.nih.gov/pubmed/25693800
http://dx.doi.org/10.1074/mcp.M113.036764

Ejemplares similares